IN2012DN01968A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01968A
IN2012DN01968A IN1968DEN2012A IN2012DN01968A IN 2012DN01968 A IN2012DN01968 A IN 2012DN01968A IN 1968DEN2012 A IN1968DEN2012 A IN 1968DEN2012A IN 2012DN01968 A IN2012DN01968 A IN 2012DN01968A
Authority
IN
India
Prior art keywords
novel process
novel
nep
inhibitors
synthesis
Prior art date
Application number
Inventor
Guoliang Zhu
Desong Shi
Junhui Wei
Fengfeng Tao
Original Assignee
Zhejiang Jiuzhou Pharm Co Ltd
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2009/074125 external-priority patent/WO2010034236A1/en
Application filed by Zhejiang Jiuzhou Pharm Co Ltd, Novartis Ag filed Critical Zhejiang Jiuzhou Pharm Co Ltd
Publication of IN2012DN01968A publication Critical patent/IN2012DN01968A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, in particular neutral endopeptidase (NEP) inhibitors.
IN1968DEN2012 2009-09-23 2010-03-23 IN2012DN01968A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2009/074125 WO2010034236A1 (en) 2008-09-24 2009-09-23 Process for the manufacture of n-acylbiphenyl alanine
PCT/CN2010/071243 WO2011035569A1 (en) 2009-09-23 2010-03-23 Process for manufacture of n-acylbphenyl alanine

Publications (1)

Publication Number Publication Date
IN2012DN01968A true IN2012DN01968A (en) 2015-08-21

Family

ID=43796233

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1968DEN2012 IN2012DN01968A (en) 2009-09-23 2010-03-23

Country Status (11)

Country Link
US (1) US20160115118A1 (en)
EP (1) EP2480523B1 (en)
JP (1) JP5894531B2 (en)
KR (2) KR101821090B1 (en)
CN (1) CN102639486B (en)
AU (1) AU2010297892B2 (en)
BR (1) BR112012006406A2 (en)
CA (1) CA2772681C (en)
IN (1) IN2012DN01968A (en)
RU (1) RU2534619C2 (en)
WO (1) WO2011035569A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010251967B9 (en) 2009-05-28 2014-04-03 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
CA2900226A1 (en) 2013-02-14 2014-08-21 Novartis Ag Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
JP6295277B2 (en) 2013-02-14 2018-03-14 ノバルティス アーゲー Substituted bisphenylbutanoic acid phosphonic acid derivatives as NEP (neutral endopeptidase) inhibitors
TW201632493A (en) 2015-02-13 2016-09-16 諾華公司 New process
WO2017051326A1 (en) 2015-09-23 2017-03-30 Novartis Ag New processes and intermediates useful in synthesis of nep inhibitors
US10377697B2 (en) 2015-12-10 2019-08-13 Novartis Ag Process and intermediates
WO2018007919A1 (en) 2016-07-05 2018-01-11 Novartis Ag New process for early sacubitril intermediates
CN109563019A (en) 2016-08-17 2019-04-02 诺华股份有限公司 The new method and intermediate of nep inhibitor synthesis
CN107778192A (en) * 2016-08-26 2018-03-09 浙江九洲药业股份有限公司 A kind of preparation method of N alcoxyls or benzyloxycarbonyl group chirality propylhomoserin
JP7138106B2 (en) 2016-12-23 2022-09-15 ノバルティス アーゲー A novel method for the initial sacubitril intermediate
UY38072A (en) 2018-02-07 2019-10-01 Novartis Ag COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60185752A (en) * 1984-03-05 1985-09-21 Mitsui Toatsu Chem Inc Production of alpha-acetamidocinnamic acid
JPS60215657A (en) * 1984-04-10 1985-10-29 Mitsui Toatsu Chem Inc Preparation of n-acylphenylalanine
JPS6245554A (en) * 1985-08-23 1987-02-27 Nippon Redarii Kk Simple production of 4-biphenylylacetic acid
CA1325222C (en) * 1985-08-23 1993-12-14 Lederle (Japan), Ltd. Process for producing 4-biphenylylacetic acid
FR2662440B1 (en) * 1990-05-22 1992-07-31 Rhone Poulenc Sante PROCESS FOR THE STEREOSELECTIVE PREPARATION OF PHENYLISOSERIN DERIVATIVES.
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Serine protease inhibiting antithrombotic agents and pharmaceutical compositions comprising them
GB2354440A (en) * 1999-07-20 2001-03-28 Merck & Co Inc Aryl amides as cell adhesion inhibitors
JP4270484B2 (en) * 2002-03-08 2009-06-03 第一ファインケミカル株式会社 Method for producing optically active phenylalanine derivative
BR0305426A (en) * 2002-07-01 2004-08-24 Upjohn Co Hsv ns5b polymerase inhibitor compounds as well as pharmaceutical composition comprising the same
US20040180943A1 (en) * 2002-07-23 2004-09-16 Augelli-Szafran Corinne Elizabeth Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis
PE20091364A1 (en) 2008-01-17 2009-10-13 Novartis Ag PROCESS FOR THE PREPARATION OF NEP INHIBITORS
CN101684077B (en) * 2008-09-24 2013-01-02 浙江九洲药业股份有限公司 Method for preparing N-acyl diphenylalanine
CN101774941A (en) * 2009-01-13 2010-07-14 浙江九洲药业股份有限公司 Method for preparing and splitting 2-acyl amino-3-biphenylyl propionic acid
CN101555211B (en) * 2009-05-13 2012-01-25 浙江九洲药业股份有限公司 Chemical synthesis method of 2-acylamino-3-biphenyl propionic acid

Also Published As

Publication number Publication date
BR112012006406A2 (en) 2016-04-12
CA2772681C (en) 2017-01-03
CN102639486B (en) 2014-12-31
CA2772681A1 (en) 2011-03-31
AU2010297892B2 (en) 2014-02-06
CN102639486A (en) 2012-08-15
JP5894531B2 (en) 2016-03-30
EP2480523A4 (en) 2013-06-26
KR101821090B1 (en) 2018-01-22
EP2480523B1 (en) 2017-03-01
WO2011035569A1 (en) 2011-03-31
KR20170002681A (en) 2017-01-06
AU2010297892A1 (en) 2012-03-22
JP2013505273A (en) 2013-02-14
RU2012116208A (en) 2013-11-10
RU2534619C2 (en) 2014-11-27
US20160115118A1 (en) 2016-04-28
KR20120093227A (en) 2012-08-22
EP2480523A1 (en) 2012-08-01

Similar Documents

Publication Publication Date Title
IN2012DN01968A (en)
MX2012003488A (en) Process for manufacture of n-acylbphenyl alanine.
MX2010002836A (en) Bortezomib and process for producing same.
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
UA106748C2 (en) Proline derivatives as cathepsin inhibitors
MY150542A (en) Cmet inhibitors
AP2757A (en) Process for preparation of HIV protease inhibitors
EA201270280A1 (en) Pyrimidine Compounds as Inhibitors in the Treatment of Tuberculosis
UA97806C2 (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
TW200728310A (en) Process for the preparation of ferri-succinylcasein
MY158910A (en) Surface modified silicic acid semi-gels
TW200740769A (en) Novel process
HK1139402A1 (en) Process for the preparation of 2-substituted-5-(1-alkylthio) alkylpyridines
MX2012010317A (en) β-hydroxyalkylamides, method for their production and use thereof.
MX2011006721A (en) Pharmaceutical formulation of nanonised fenofibrate.
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
SG143133A1 (en) Continuous processes for the production of ethoxylates
MX2010001962A (en) Method for producing 4-aminobut-2-enolides.
EA201101613A1 (en) METHOD OF OBTAINING SEVELAMERA
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
EA201001401A1 (en) IMPROVED IZOMALTIS-CONTAINING TABLETS AND METHOD OF THEIR PRODUCTION
MX2013002656A (en) New process.
MX2012001875A (en) Process for the preparation of cathepsin s inhibitors.
MX2012003888A (en) Surface modified silicic acid semi-gels.
MX2009003196A (en) Process for the preparation of î³-butyrolactones.